EU statement also shifts focus onto Spain

SpaceX IPO eyes $2T valuation, P/S > 100. AMZN offers better value at P/E 36.

WBTN jumps 6% on AI avatar deal, but remains volatile & down 10.8% YTD.

AESI jumps 2.9% on oil spike; GPRE up 2.6%. AESI's 74% YTD gain hits new highs.

VZ beats EPS estimates, boosting shares 3%. Mixed revenue, but strong cash flow outlook signals value.

Teva's pivot shows growth in key drugs like Austedo (34% sales jump). Q1 earnings may dip, but 2027 EPS targets rise 17%.

CVLT drops 4.2% on hold rating; 2027 growth forecast faces risk. Down 27.9% YTD.

Morgan Stanley says dollar risks are increasingly skewed to the downside as FX markets grow less sensitive to energy war headlines, though refined product shortages remain a key upside risk for the currency.